Design, Synthesis, and Antitumor Activity of Erlotinib Derivatives

Nineteen erlotinib derivatives bearing different 1,2,3-triazole moieties were designed, synthesized, and evaluated for their potential against different cancer cell lines. The structures of the synthesized compounds were confirmed via1H NMR, 13C NMR, and HR MS. Preliminary antitumor activity assay r...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Long-fei Mao, Zhen-Zhen Wang, Qiong Wu, Xiaojie Chen, Jian-Xue Yang, Xin Wang, Yue-Ming Li
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2022-04-01
סדרה:Frontiers in Pharmacology
נושאים:
erlotinib
EGFR
anticancer
drug-resistant cancer cell lines
1,2,3-triazole
גישה מקוונת:https://www.frontiersin.org/articles/10.3389/fphar.2022.849364/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים